Background. Regional differences in the prevalence of Panton-Valentine leukocidin (PVL) and PVL isoformharboring strains as well as in the local population structure of Staphylococcus aureus may influence the clinical spectrum of S. aureus infections.
demonstrated sequence variations within the PVL gene lukSF-PV [11] [12] [13] . Molecular modeling suggests that the amino acid substitution of His 176 to Arg 176 (H and R isoforms) may affect PVL function [11] ; however, clinical studies are lacking. USA300 isolates carry the R isoform, but most other clones isolated outside the United States carry the H isoform [11, 12] . Fifty percent of our PVL + CA-MRSA and methicillin-susceptible S. aureus (MSSA) isolates from northern Australia carry the R isoform. The majority of these isolates are CC93.
Thus, the diverse molecular epidemiology of S. aureus in tropical northern Australia provides a unique opportunity to investigate whether clinical and epidemiological differences exist between infections caused by (1) PVL + and PVL Ϫ isolates, (2) PVL H isoform-and PVL R isoform-harboring isolates, and (3) different lineages, including CC75 and CC93. In addition, we placed the population structure of S. aureus in northern Australia within the context of recent findings regarding S. aureus in East Asia.
METHODS
The 330-bed Royal Darwin Hospital (RDH) is located in the tropical Top End of the Northern Territory of Australia ( Figure  1 ). It is the tertiary referral center for the capital city, Darwin, along with 2 regional hospitals and 170 remote communities, all together encompassing a population of 190,000 and an area of 510,000 km 2 . Both pediatric and adult patients are cared for at the RDH and are included in this study. Indigenous Australians comprise 27% of the total population but account for 150% of the RDH inpatient and emergency department population. Ethical approval for the study was granted by the Human Research Ethics Committee of the Northern Territory Department of Health and Families and the Menzies School of Health Research.
We initially conducted a case-control study that compared infections caused by non-multidrug-resistant MRSA (nm-MRSA) with those caused by MSSA at the RDH over a 12month period beginning April 2006 [14] . For the present study, we matched eligible patients with nmMRSA infection to the next eligible patient with MSSA infection, using sequential laboratory specimen receipt numbers. We collected information on demographics, health care-associated risk factors, comorbidities, clinical details of the infection, treatment details, and outcomes at discharge. Sepsis was defined in adults and children on the basis of the systemic inflammatory response syndrome criteria [15, 16] .
The RDH laboratory identified S. aureus isolates by standard methods and conducted susceptibility testing using an automated Vitek 2 instrument (version 4.01; bioMérieux) and the Kirby-Bauer disc diffusion method, in accordance with Clinical and Laboratory Standards Institute standards [17] . A disc approximation test (D test) was used to detect inducible clin-damycin resistance. Real-time polymerase chain reaction (PCR) verified the identity of nmMRSA isolates by confirming the presence of the nucA and mecA genes [18] . We phenotypically defined nmMRSA as those resistant to !3 non-b-lactam antibiotic classes and considered these to represent CA-MRSA strains. Antibiotic phenotype has previously been shown to accurately predict CA-MRSA genotypes [19] , with validation in recent Australian studies [4, 20] .
We genotyped isolates by means of a single-nucleotide polymorphism (SNP) genotyping system based on the multilocus sequence type (MLST) database, as previously elsewhere [18, 21] . In short, a kinetic PCR method was used to interrogate 8 highly discriminatory SNPs, allowing isolates to be assigned into CCs. To confirm isolates as CC93, we also performed a high-resolution melt (HRM) assay interrogating aroE position 252 [22] . We determined the presence of the lukF-PV gene in all isolates [18, 21] and then used an HRM assay to determine the H and R isoform status of all PVL + isolates. The primers for this HRM assay are PVL527F (5 -CAACAAAACTATATCA-GTGAAGTAGAAC-3 ) and PVL527R (5 -TCCCCATTGAACA-CTTTTTGAA-3 ). The isoforms were clearly discriminated; the melting temperature of the amplified product for the H isoform was 1ЊC less than that for the R isoform [23] .
Comparisons of infections due to PVL + and PVL Ϫ isolates and between CCs were stratified by methicillin resistance (the study included all nmMRSA isolates but only a random subset of MSSA isolates). Statistical significance for crude analysis of dichotomous variables was determined using the x 2 test or the Fisher exact test; for continuous variables, the Student t test or analysis of variance was used. Nonparametric data were compared using the Mann-Whitney U test. We conducted multivariate logistic regression analysis with stepwise backward elimination of variables to identify associations with the outcomes of PVL status, PVL isoform status, sepsis, and abscess formation. Variables with a univariate P value of !.20 were included in the initial models. The likelihood ratio test was used to assess the statistical significance of candidate risk factors. Two-sided P values of !.05 were considered significant. Statistical analysis was performed with Stata software (version 10.1; StataCorp). Phylogenetic analysis was performed on concatenated MLST data, using the neighbor-joining algorithm (Kimura 2-parameter distance estimation) as implemented in MEGA software (version 4.1) [24] .
RESULTS
During the study period, 1693 nonduplicate S. aureus isolates were recovered from patients at the RDH, with MSSA outnumbering nmMRSA at a ratio of 4.3:1. There were 1265 MSSA (75%), 291 nmMRSA (17%), and 137 multidrug-resistant MRSA (8%) isolates. Patient characteristics, outcomes, and corresponding molecular data from 239 eligible nmMRSA and 239 matched MSSA isolates were included in the case-control analysis. Twenty-two CCs were represented ( Figure 2 ). In contrast, we have previously shown that only 1% P ! .001 of multidrug-resistant MRSA isolates were community acquired in our setting [14] . The proportional incidence of isolates harboring PVL stratified by age group showed a steady decline with age for both nmMRSA and MSSA ( Figure 3 ). Of patients ). Skin and soft-tissue infections and abscesses were P ! .001 seen more commonly in PVL + infections, but there was no difference in bacteremia. Despite a greater proportion of patients requiring surgery, length of stay was shorter for PVL + infections CC were not associated with sepsis. The presence of PVL was associated with abscess formation on multivariate logistic regression modeling for both nmMRSA (OR, 10.3 [95% CI, 4.5-23.9]) and MSSA (OR, 11.4 [95% CI, 5.4-23.7]). Table 2) . A multivariate logistic regression model also found no significant associations.
Comparison between isolates harboring PVL H and R isoforms. There was no difference across all characteristics when comparing infections due to isolates harboring H and R isoforms on univariate analysis (
Population structure and clinical outcomes of different clones. Phylogenetic analysis ( Figure 2 ) demonstrated the divergence of CC75 from all other clones and the clustering of PVL + isolates within the group 1 clade. Given that we took a random sample of MSSA isolates that is likely to be representative of the overall MSSA population and that MSSA outnumbered nmMRSA at a 4.3:1 ratio, we estimate that MSSA accounts for ∼70% of PVL + isolates. Almost all group 1b clade (CC93 and CC121) isolates were PVL + and represented 87% (83/95) of all PVL + MSSA isolates.
We compared the clinical features and isolate characteristics of CCs that were represented by 120 isolates when stratified by methicillin resistance (Table 3 ). Together, these lineages comprised 69% (331/478) of all isolates. Across-group comparisons revealed significant differences for patients with regard to age, sex, ethnicity, remote residence, presence of comorbidities, health care-associated risk factors, nosocomial acquisition, presentation with abscess, length of stay, and receipt of surgery. There were also significant differences in antibiotic resistance profile and the presence of PVL. There was no difference in the outcomes of bacteremia and sepsis.
The principally PVL + clones CC30, CC93, and CC121 affected patients with fewer comorbidities and health care-associated risk factors. Only 7% (14/211) of these infections were acquired in the hospital, indicating a lack of penetration of these community clones into the nosocomial environment. In contrast, CC1, CC5, and CC75 affected patients with more comorbidities and health care-associated risk factors and had higher rates of nosocomial acquisition. 3 (3) 25 (17) 0.2 (0.0-0.5)
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.919 0 (0) CC93 was numerically the predominant clone, comprising 26% (62/239) of nmMRSA and 20% (47/239) of MSSA isolates. All harbored the PVL R isoform. There were no significant differences between CC93 nmMRSA and CC93 MSSA. CC75 was principally isolated from Indigenous Australian patients (82% [18/22] ;
for the comparison with non-CC75 P p .006 isolates) and appeared less likely to cause presentations with sepsis. Erythromycin and inducible clindamycin resistance was present in 150% of CC1 and CC121 isolates.
DISCUSSION
There are a number of parallels and contrasts between the community-associated MRSA epidemics described in North America and our experience in northern Australia [25, 26] . In North America, the USA400 clone appeared to be most prominent before 2001 [27] but has since been displaced by USA300 across most of the United States [3] . Both USA300 and USA400 typically express PVL. In northern Australia, despite the presence of community-associated MRSA since at least the early 1990s [28] , there continues to be a diversity of strains, with the 3 major clones together representing ∼75% of isolates. One of these clones, CC1, is usually PVL Ϫ . However, our finding that a significant proportion of both community-associated MRSA and MSSA isolates are PVL + CC93 reflects the growing emergence of this lineage across Australia since it was first described in 2000 [8] . As with USA300 and USA400, cases of severe staphylococcal disease have been described with CC93 [29, 30] .
Early epidemiological studies highlighted the association between PVL and necrotizing pneumonia, furunculosis, and severe bone and joint infections [9, 10, 31] . Evidence supporting the pathogenic role of PVL in mice and rabbit pneumonia models followed [32, 33] . However, other studies have cast doubt on these findings and questioned the role of PVL in the pathogenesis of S. aureus infection [34, 35] . Of PVL isoforms, the H and R isoforms appear to be the most significant numerically and by geographic distribution. Molecular models suggest that the R isoform may lead to increased pore formation and, therefore, greater leukotoxicity [11] . In the present study, we have defined epidemiological associations with PVL, as well as with PVL H and R isoforms, in a large prospective sample of patients with infections caused by diverse community-associated S. aureus clones. Many previous studies have principally focused on community-associated MRSA; one of the key results of this study is the unanticipated high rate of PVL positivity in MSSA isolates. Our findings demonstrate a clear difference in the patient population affected and disease between PVL + and PVL Ϫ isolates, irrespective of methicillin resistance phenotype. Patients with PVL + isolates were younger by close to 10 years on average and had fewer comorbidities. Despite PVL being significantly associated with sepsis, patients with PVL + infections had a shorter length of stay. Patients with PVL + infections were less likely to have health care-associated risk factors, regardless of methicillin resistance phenotype. In other words, even among community-associated strains of S. aureus, PVL + strains were much more likely to be truly community acquired. Only 6% (13/223) of PVL + isolates were nosocomially acquired, compared with 21% (54/255) of PVL Ϫ isolates and 62% of multidrug-resistant MRSA isolates [14] . PVL + strains are endemic in our population and cause discharging skin abscesses but have made minimal incursions into the hospital setting. There rightly are concerns that PVL + community-associated MRSA strains such as USA300 will infiltrate and replace health care-associated genotypes of MRSA [36] . However, it is not clear whether traditional transmission models for MRSA can be applied to CA-MRSA [37] . Our findings suggest that, in our setting, true nosocomial transmission of PVL + strains (both nmMRSA and MSSA) is uncommon.
Table 2. Comparison of the Characteristics of Panton-Valentine Leukocidin Histidine (H) and Arginine (A) Isoform Infections
Another striking finding was that the age-specific incidence of PVL + compared with PVL Ϫ infections declined after a peak in the 20-39-year-old age group. Serological studies have demonstrated that PVL + S. aureus infections elicit an anti-PVL immunoglobulin G response [38, 39] . However, no consistent correlation was found between antibody levels and increasing age among individuals without evidence of current S. aureus infection [39] . Prospective longitudinal studies would help to determine whether such antibodies provide protective immunity or perhaps contribute to host susceptibility [40] and thus effect the age-specific incidence of PVL + infection.
We found no difference in the epidemiological and clinical characteristics of infections caused by PVL H isoform-and PVL R isoform-harboring isolates, suggesting to us that the R isoform confers no differential clinical effect. This accords with recent laboratory findings of no difference in leukotoxicity between strains bearing the H isoform and those bearing the R isoform [41] . However, because the majority of isolates harboring the R isoform belonged to CC93, we cannot exclude the lesser possibility that the genomic background or other virulence factors carried by CC93 neutralize a real clinical difference. Notably, the other clone of S. aureus that typically harbors the R isoform is USA300. While not as extensive, the prevalence and distribution of CC93 in Australia is also expanding [4, 8] . Whether the R isoform enhances the transmissibility of S. aureus compared with the H isoform requires further exploration.
Previous work has demonstrated that all nasal-colonizing S. aureus genotypes can cause invasive disease [42, 43] . Our examination of the local population structure of S. aureus and associated detailed clinical features revealed several additional points. Both CC1 and CC5, common lineages locally and globally, typically caused disease in older, sicker patients. Carriage studies of S. aureus have demonstrated PVL Ϫ strains of CC1 and CC5 to be common nasal colonizers [6, 42, 44, 45] . Our findings suggest that these strains are well-adapted human commensals that mainly cause opportunistic infections in vulnerable hosts.
In contrast, CC93 and the other PVL + clones affect younger, healthier patients. CC93 was the most common clone identified in our collection, being significantly represented among both nmMRSA and MSSA strains. Previous typing of the staphylococcal protein A gene (spa) has revealed similar diversity of spa types in both the nmMRSA and MSSA CC93 isolates from northern Australia. Rather than a recent clonal expansion of a particular CC93 MRSA spa type after a single acquisition of staphylococcal cassette chromosome (SCC) mec, the multiple CC93 MRSA spa types in a geographically and chronologically localized collection of isolates is better explained by either earlier SCCmec acquisition with subsequent spa type diversification or multiple independent acquisitions of SCCmec [22] .
An unexpected finding was the importance of CC121, an exclusively MSSA clone in our collection that comprised 15% (37/239) of all MSSA isolates, all but one of which was PVL + . Colonization surveys in remote western Australian Indigenous communities revealed CC121 to comprise 6.7% of MSSA isolates [45] , but ours is the first report to attribute clinical disease to this clone in Australia. The effect of CC121 and CC93 in Australia has likely been previously underestimated because of a focus on nmMRSA.
The phylogenetically diverged CC75 lineage is one of emerging interest. Apart from impetigo [18] , this is the first report, to our knowledge, that CC75 is capable of causing clinical disease (including bacteremia) similar to that of other S. aureus clones. However, 2 observations may indicate a comparatively less virulent phenotype. First, CC75 is underrepresented among clinical isolates, representing only 9% of nmMRSA isolates compared with 71% of nmMRSA isolates recovered from impetigo lesions in remote Indigenous Australian communities [18] . Second, the observed rates of sepsis due to CC75 are probably lower than with other lineages.
Intriguingly, the presence of CC75 has recently been reported in Cambodia and possibly in Indonesia and Malaysia [6] . This may relate to well-described direct population contacts between Macassan traders from Indonesia and northern Australian Indigenous people that predated the European colonization of Australia [46] . Also, a relative abundance of group 1b strains in Asia [6, 44] compared with elsewhere in the world has been noted, and we have found a similar overrepresentation of this clade, with CC121 and CC93 together comprising 26% and 35% of our nmMRSA and MSSA isolates, respectively. In summary, the emerging picture of S. aureus in the Top End of the Northern Territory of Australia is of a mixture of globally prevalent lineages (such as CC1, CC5, and CC30) coexisting with lineages that belong to either the highly diverged CC75 or the group 1b clade. CC121 is very widespread in the Asia-Pacific region, whereas CC93 appears to have emerged in Australia.
Limitations of our study include not collecting and typing all MSSA isolates presenting to the laboratory during the study period. However, MSSA isolates were collected in a random manner by sequential matching of laboratory receipt codes throughout the study period and should be representative of all MSSA isolates during this period. Importantly, we have been careful to stratify the analysis by methicillin resistance and have demonstrated that the associations with PVL were consistent for both nmMRSA and MSSA. However, it must be borne in mind that epidemiological associations with PVL should be distinguished from pathophysiological proof of causation. We did not perform SCCmec typing, and the SNP-based typing method does not provide the resolution of full MLST or pulsedfield gel electrophoresis. Thus, we cannot determine differences in the clinical features of some subclones within CCs.
In conclusion, we have determined the clinical disease spectrum caused by prevalent strains of S. aureus in northern Australia, including descriptions for CC93 and CC75. While differences in clinical disease existed on the basis of the genetic background as assessed by CC, these differences, including the outcome of sepsis, were principally explained by the presence of PVL. Even among community-associated lineages of S. aureus, PVL was a strong predictor of truly community-acquired disease. In our setting, the greater burden of PVL + disease is carried by MSSA, and focusing on nmMRSA alone will lead to underrecognition and underestimations of the effect of PVL + clones, such as CC93 and CC121.
